2,992
回編集
差分
ナビゲーションに移動
検索に移動
→scheme
{|class="wikitable" style="width:1200px"
|-
!colspan="4"|NRTI <br>Nucleoside Reverse Transcriptase Inhibitor
|-
!style="width:25%"|
**Caucasians need HLA-testing before treament
|}
<div style="float:left; padding-right:1em;">
{|class="wikitable" style="width:400px"
|-
!colspan="3"|
NNRTIM<br>Non-Nucleoside Reverse Transcriptase Inhibitor
|-
!style="width:33.3%"|
Efavirenz<br>EFV
|style="width:33.3%|
*1st choice in NNTRIs
|style="width:33.3%|
*neuropsychiatric side effects
**dizzyness, insomnia, nightmares, depression, psychoses
*rash
*gynecomastia 5-6% in Africa
|-
!Nevirapine<br>NVP
|
*not effective against HIV-2
|
*rash to Stevens Johnson syndrome
*hepatic toxicity
*interact with rifampicine
**never use in HIV-TB
|}
</div>
<div style="float:left; padding-right:1em;">
{|class="wikitable" style="width:400px"
|-
!colspan="3"|
INI<br>Integrase Inhibitor
|-
!style="width:33.3%"|
Dolutegravir<br>DTG
|style="width:33.3%"|
|style="width:33.3%"|
|-
!Raltegravir<br>RAL
|
|
|}
</div>
===NRTIs===
